Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 7, 1996, Pages 857-863

  Van Kleef, Ellen M ^a   Fingerle, Jürgen ^b   Daemen, Mat J A P ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

AT receptor antagonists; balloon injury; growth control; restenosis

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; BALLOON CATHETER; BLOOD VESSEL INJURY; CAROTID ARTERY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INDUCED DISEASE; ENZYME INHIBITION; GROWTH REGULATION; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030018519     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.7.857     Document Type: Article

References (45)

1. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
2. Laporte S, Escher E. Neointima formation after vascular injury is angiotensin II mediated. Biochem Biophys Res Commun. 1992;187:1510-1516.
3. Janiak P, Libert O, Vilaine JP. Role of the renin-angiotensin system in neointima formation after injury in rabbits. Hypertension. 1994;24:671-678.
4. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
5. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
6. Scott-Burden T, Hahn AWA, Resink TJ, Buhler FR. Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol. 1990;16:S36-S41.
7. Corriu C, Andre P, Schott C, Michel M, Stoclet JC. ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells. Am J Physiol. 1994;266:H63I-H636.
8. Chiu AT, Roscoe WA, McCall D, Timmermans PBMWM. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor. 1991;1:133-140.
9. Briand V, Riva L, Galzin AM. Angiotensin II induces DNA synthesis in cultured vascular smooth muscle cells. Br J Pharmacol. 1992;105:82P. Abstract.
10. Natarajan R, Gonzales N, Nadler J. Angiotensin-II induced protein and DNA synthesis in vascular smooth muscle cells (VSMC) is enhanced in elevated glucose. FASEB J. 1992;6:A1031. Abstract.
11. Clozel JP, Hess P, Michael C, Schietinger K, Baumgartner HR. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension. 1991;18(suppl II):II-55-II-59.
12. Viswanathan M, Stromber C, Seltzer A, Saavedra JM. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta. J Clin Invest. 1992;90:1707-1712.
13. Viswanathan M, Seltzer A, Saavedra JM. Heterogeneous expression of angiotensin II AT1 receptors in neointima of rat carotid artery and aorta after balloon catheter injury. Peptides. 1994;15:1205-1212.
14. Janiak P, Bruneval P, Pillon A. Quantitative autoradiographic study of angiotensin II receptor subtypes (AT1 and AT2) in the neo-intima formation after balloon injury in the rat carotid artery. Eur Heart J. 1994;15(suppl):116. Abstract.
15. Janiak P, Pillon A, Prost J-F, Vilaine J-P. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension. 1992;20:737-745.
16. Wong PC, Christ DD, Timmermans PBMWM. Enhancement of losartan (Dup753) induced angiotensin II antagonism by PD123177 in rats. Eur J Pharmacol. 1992;220:267-270.
17. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfied P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:206-251.
18. Kauffman RF, Bean JS, Zimmerman KM, Brown RF, Steinberg MI. Losartan, a nonpeptide angiotensin II (ANG II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci. 1991;49:223-228.
19. Osterrieder W, Muller RK, Powell JS, Clozel JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension. 1991;18(suppl 4):II-60-II-64.
20. Clozel J-P, Müller RKM, Nat D, Roux S, Fischli W, Baumgartner H-R. Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats. Circulation. 1993;88:1222-1227.
21. Anglin S, Jagoe R, Polak JM, McEwan JR. Inhibition of intimal hyperplasia by heparin and an angiotensin II antagonist in a rat model of angioplasty restenosis. Br Heart J. 1993;69:P49. Abstract.
22. Azuma H, Niimi Y, Hamasaki H. Prevention of intimai thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Br J Pharmacol. 1992;106:665-671.
23. Prescott MG, Webb RL, Reidy MA. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 1991;139:1291-1296.
24. Farhy RD, Carretero OA, Khang-Loon H, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 1993;72:1202-1210.
25. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
26. Daemen MJAP, De Mey JGR. Heterogeneity of arterial structural changes. Hypertension. 1995;25:464-473.
27. Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
28. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
29. van Kleef EM, Smits JF, De Mey JG, Cleutjens JP, Lombards DM, Schwartz SM, Daemen MJ. Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res. 1992;70:1122-1127.
30. Smits JEM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 1992;20:772-778.
31. Daemen MJAP, Smits JEM. Inhibition of interstitial myocardial DNA synthesis after coronary artery ligation in the rat by the angiotensin subtype 2 receptor antagonist PD123319. Eur Heart J. 1993;14 (suppl):414. Abstract.
32. Zimmerman BG. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci. 1981;60:343-348.
33. Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther. 1990;255:584-592.
34. Starke K, Werner U, Schumann HJ. Wirkung von Angiotensin auf Funktion und Noradrenalinabgabe isolierter Kaninchenherzen im Ruhe und bei sympathicusreizung. Schmiedebergs Arch Pharmacol. 1969;265:170-186.
35. Zimmerman BG, Whitmore L. Effect of angiotensin and phenoxybenzamine in vessels during sympathetic nerve stimulation. Int J Neuropharmacol. 1967;6:27-38.
36. van Kleef EM, Smits JFM, Schwartz SM, Daemen MJAP. Doxazosin blocks the angiotensin II induced smooth muscle cell DNA synthesis in the media, but not in the neointima of the rat carotid artery after balloon injury. Cardiovasc Res. In press.
37. 1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall: modulation of responsiveness after vascular injury. Arterioscler Thromb Vasc Biol. In press.
38. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a nonpressor mechanism. Hypertension. 1991;17:626-635.
39. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer for angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
40. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993;72:1245-1254.
41. Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: roles of phospholipid-derived second messengers. Circ Res. 1993;73:424-438.
42. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
43. Serruys PW. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multi-center, randomized, double-blind placebo-controlled trial. Circulation. 1992;86:100-110.
44. Rakugi H, Kim D-K, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest. 1994;93:339-346.
45. Sartore S, Scatena M, Chiavegato A, Faggin E, Giuriato L, Pauletto P. Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J Vasc Res. 1994;31:61-81.